43 Recruiting Studies Using Dasatinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Dasatinib
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
📍 M D Anderson Cancer Center — Houston, Texas
Chronic Phase Chronic Myelogenous Leukemia
View Study & Checklist ➔Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
📍 Wake Forest Health Sciences — Winston-Salem, North Carolina
Alzheimer Disease, Early Onset
View Study & Checklist ➔Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
📍 Stanford University — Palo Alto, California
Lymphoblastic Leukemia
View Study & Checklist ➔Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
📍 Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
Chronic Myeloid Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Improving Physical Ability and Cellular Senescence Elimination in HIV
📍 University of California, Los Angeles CARE Center CRS (Site ID: 601) — Los Angeles, California
HIV
View Study & Checklist ➔Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
📍 University of California, Los Angeles — Los Angeles, California
Prostate Cancer
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
📍 Mount Sinai Hospital — New York, New York
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔ALSENLITE: Senolytics for Alzheimer's Disease
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Mild Cognitive Impairment
View Study & Checklist ➔Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
📍 Boston Children's Hospital — Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist ➔Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
📍 Washington University School of Medicine — St Louis, Missouri
Schizophrenia
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
📍 University of California, San Francisco (UCSF) — San Francisco, California
Hematologic Malignancies
View Study & Checklist ➔Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Metastatic Pancreatic Adenocarcinoma
View Study & Checklist ➔Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
📍 OHSU Knight Cancer Institute — Portland, Oregon
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist ➔Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
📍 Rocky Mountain Cancer Centers — Denver, Colorado
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
View Study & Checklist ➔An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Frailty
View Study & Checklist ➔Bioequivalence Studies of Dasatinib 100 Mg
📍 CAIMED — Chía, Cundinamarca
Myeloma Multiple
View Study & Checklist ➔Senolytics for Secondary Progressive MS
📍 Ohio State Martha Morehouse Outpatient Care — Columbus, Ohio
Multiple Sclerosis (MS) Secondary Progressive
View Study & Checklist ➔Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Recurrent Multiple Myeloma
View Study & Checklist ➔Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
📍 Novant Health Presbyterian Hemby Children's Hospital — Charlotte, North Carolina
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Glioma
View Study & Checklist ➔Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
📍 Cedars Sinai Medical Center — Los Angeles, California
Obesity
View Study & Checklist ➔Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
📍 Cross Cancer Institute — Edmonton, Alberta
Lymphoma, Non-Hodgkin
View Study & Checklist ➔Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Chronic Myeloid Leukemia
View Study & Checklist ➔Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
📍 Rady Children's Hospital — San Diego, California
T-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔Asciminib Roll-over Study
📍 Michigan Med University of Michigan — Ann Arbor, Michigan
Chronic Myelogenous Leukemia
View Study & Checklist ➔Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
Neuroblastoma
View Study & Checklist ➔ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
B-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
📍 University of Chicago Medical Center — Chicago, Illinois
Lymphoblastic Leukemia
View Study & Checklist ➔Dasatinib for HIV-1 Reservoir Reduction
📍 Northwestern University CRS (Site # 2701) — Chicago, Illinois
HIV Infections
View Study & Checklist ➔Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
📍 The Barbara Ann Karmanos Cancer Institute — Detroit, Michigan
Chronic Phase Chronic Myelogenous Leukemia
View Study & Checklist ➔Pilot Trial for Treatment of Recurrent Glioblastoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Glioblastoma
View Study & Checklist ➔